Table 3

Gene–environment interaction of human leukocyte antigen shared epitope (HLA-SE) and smoking in the Nurses’ Health Studies

HLA-SESmoking statusAll RASeropositive RASeronegative RA
OR (95% CI)*OR (95% CI)†‡OR (95% CI)†§¶
NoneNever1.00 (reference)1.00 (reference)1.00 (reference)
NoneEver0.99 (0.65 to 1.51)1.05 (0.66 to 1.68)1.04 (0.64 to 1.69)
AnyNever1.65 (1.05 to 2.61)1.78 (1.08 to 2.95)1.18 (0.67 to 2.08)
AnyEver2.14 (1.39 to 3.29)2.94 (1.84 to 4.69)1.23 (0.72 to 2.10)
Additive interaction:
    AP (95% CI)0.23 (−0.14 to 0.61)0.38 (0.05 to 0.70)0.004 (−0.69 to 0.70)
    p For interactionpadd = 0.23padd = 0.02padd = 0.99
    RERI0.49 (−0.35 to 1.33)1.10 (−0.02 to 2.22)0.005 (−0.85 to 0.86)
    Synergy Index1.77 (0.50 to 6.25)2.32 (0.72 to 7.47)1.02 (0.02 to 47.34)
Multiplicative interaction:
    p For interactionpmulti = 0.38pmulti = 0.18pmulti = 1.00
OR (95% CI)*OR (95% CI)†‡OR (95% CI)
None⩽10 pack-years smoking1.00 (reference)1.00 (reference)1.00 (reference)
None>10 pack-years smoking1.10 (0.73 to 1.67)1.08 (0.67 to 1.72)1.16 (0.72 to 1.89)
Any⩽10 pack-years smoking1.58 (1.08 to 2.33)1.72 (1.13 to 2.61)1.09 (0.68 to 1.77)
Any>10 pack-years smoking2.75 (1.75 to 4.31)3.61 (2.26 to 5.78)1.45 (0.81 to 2.56)
Additive interaction:
    AP (95% CI)0.39 (0.08 to 0.69)0.50 (0.24 to 0.77)0.13 (−0.49 to 0.75)
    p For interactionpadd = 0.01padd<0.001padd = 0.68
    RERI1.06 (−0.06 to 2.17)1.82 (0.35 to 3.30)0.19 (−0.75 to 1.13)
    Synergy index2.54 (0.81 to 7.97)3.30 (1.06 to 10.33)1.74 (0.07 to 42.22)
Multiplicative interaction:
    p For interactionpmulti = 0.14pmulti = 0.05pmulti = 0.74
  • padd is the p value for the attributable proportion due to interaction, pmulti is the p value for multiplicative interaction term between binary smoking variable and binary HLA-SE genotype with 1 degree of freedom.

  • *Conditional logistic regression, adjusting for parity, breast feeding and menstrual irregularity, and age at menarche, menopausal status and postmenopausal hormone use. †Unconditional logistic regression adjusting for year of birth, parity, breast feeding and menstrual irregularity, and age at menarche, menopausal status and postmenopausal hormone use. ‡Seropositive RA cases and all controls; §seronegative RA cases and all controls.

  • AP, attributable proportion due to interaction, an index of additive interactions between binary smoking variable and binary HLA-SE genotype; RA, rheumatoid arthritis; RERI, relative excess risk due to interaction.